Figure 2.
Biodistribution profiles of 111indium oxine-labeled poly(ethylene oxide)-modified poly(ɛ-caprolactone) (PCL) nanoparticles (A) and poly(ethylene oxide)-modified poly(β-amino ester) (PbAE) (B) nanoparticles in mice.
Biodistribution profiles of 111indium oxine-labeled poly(ethylene oxide)-modified poly(ɛ-caprolactone) (PCL) nanoparticles (A) and poly(ethylene oxide)-modified poly(β-amino ester) (PbAE) (B) nanoparticles in mice.